Affinity DataIC50: 8nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human platelets.More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human platelets.More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human platelets.More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human platelets.More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human platelets.More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 27nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human platelets.More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 53nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 68nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 72nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 72nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 82nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 96nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 97nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 129nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 210nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 260nMAssay Description:Inhibition of radiolabeled fibrinogen binding to activated human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 470nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 630nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 720nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 770nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.06E+3nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.37E+3nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.41E+3nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+4nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: 8.20E+4nMAssay Description:Ability of the compound to inhibit the aggregation of fixed human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: >2.50E+5nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: 1.01E+6nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: >1.65E+6nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: >1.75E+6nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: 1.93E+6nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair
Affinity DataIC50: >2.35E+6nMAssay Description:Inhibition of HUVEC adhesion to fibrinogen-coated platesMore data for this Ligand-Target Pair